Commission Regulation (EU) 2023/1141 of 1 June 2023 refusing to authorise certain health claims made on foods, other than those referring to the reduction of disease risk and to children’s development and health (Text with EEA relevance)

• CELEX: Regulation (EU) 2023/1141
• Articles: 3

Article 1

The health claims listed in the Annex to this Regulation shall not be included in the Union list of permitted health claims as provided for in Article 13(3) of Regulation (EC) No 1924/2006.

Article 2

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .

Schedules & Appendices

ANNEX Rejected health claims

ANNEX

Rejected health claims

Application – Relevant provisions of Regulation (EC) No 1924/2006

Nutrient, substance, food or food category

Claim

EFSA opinion reference

Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data

Beta-glucans sourced from oats and/or barley, incorporated into ready-to-eat breakfast cereals manufactured via pressure cooking (i.e. either by batch cooking or extrusion), and present at a level of at least 1,3 g per 25 g available carbohydrate in the ready-to-eat cereal

Consumption of beta-glucans from oats and/or barley in a ready-to-eat breakfast cereal contributes to a reduction of the blood glucose rise after that meal

Q-2020-000447

Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data

Affron ® , aqueous saffron extract, with the sum of crocins and safranal concentration > 3,5 % and dextrin as inert carrier

Affron ® contributes to maintain a healthy mood by reducing the negative traits of depressive and anxiety feelings

Q-2020-00617

Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data

MegaNatural ® -BP grape seed extract made entirely of California-grown grapes containing biologically active constituents: total phenolics (90–93 %), gallic acid (≥ 2 %) and catechin and epicatechin (≥ 5 %). The distribution of phenolic compounds in the MegaNatural ® -BP is on average 9 % monomers, 69 % oligomers and 22 % polymers

MegaNatural ® -BP helps maintain healthy blood pressure

Q-2020-00718

Article 13(5) health claim based on newly developed scientific evidence and/or including a request for the protection of proprietary data

Frutalose ® chicory oligofructose

Frutalose ® chicory oligofructose contributes to regular bowel function by increasing stool frequency

(And three other alternative wordings)

Q-2020-00631